Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
Frontiers in Immunology
|
October 24, 2022
Pulsed radiotherapy to mitigate high tumor burden and generate immune memory
Duygu Sezen, Hampartsoum B Barsoumian, Kewen He, et al.
Cancer Immunology Research
|
April 18, 2020
SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti-PD-1-Resistant Model of Non-Small Cell Lung Cancer
Dawei Chen, Hampartsoum B Barsoumian, Liangpeng Yang, et al.
Frontiers in Immunology
|
January 3, 2022
Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases
Kewen He, Hampartsoum B Barsoumian, Genevieve Bertolet, et al.
Molecular Therapy. Nucleic Acids
|
December 17, 2015
In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation
Maria Angelica Cortez, David Valdecanas, Sharareh Niknam, et al.
Journal of Nanobiotechnology
|
December 13, 2021
A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model
Yun Hu, Sébastien Paris, Hampartsoum Barsoumian, et al.
Cancer Letters
|
May 11, 2018
Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells
Ailin Li, Hampartsoum B Barsoumian, Jonathan E Schoenhals, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 9, 2021
Radiation Therapy Enhanced by NBTXR3 Nanoparticles Overcomes Anti-PD1 Resistance and Evokes Abscopal Effects
Yun Hu, Sébastien Paris, Hampartsoum Barsoumian, et al.
Cancer Immunology Research
|
September 5, 2014
Combining radiation and immunotherapy: a new systemic therapy for solid tumors?
Chad Tang, Xiaohong Wang, Hendrick Soh, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 1, 2024
Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy
Kewen He, Nahum Puebla-Osorio, Hampartsoum B Barsoumian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 6, 2014
Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer
Maria Angelica Cortez, David Valdecanas, Xiaochun Zhang, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
Frontiers in Immunology
|
October 24, 2022
Pulsed radiotherapy to mitigate high tumor burden and generate immune memory
Duygu Sezen, Hampartsoum B Barsoumian, Kewen He, et al.
Cancer Immunology Research
|
April 18, 2020
SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti-PD-1-Resistant Model of Non-Small Cell Lung Cancer
Dawei Chen, Hampartsoum B Barsoumian, Liangpeng Yang, et al.
Frontiers in Immunology
|
January 3, 2022
Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases
Kewen He, Hampartsoum B Barsoumian, Genevieve Bertolet, et al.
Molecular Therapy. Nucleic Acids
|
December 17, 2015
In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation
Maria Angelica Cortez, David Valdecanas, Sharareh Niknam, et al.
Journal of Nanobiotechnology
|
December 13, 2021
A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model
Yun Hu, Sébastien Paris, Hampartsoum Barsoumian, et al.
Cancer Letters
|
May 11, 2018
Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells
Ailin Li, Hampartsoum B Barsoumian, Jonathan E Schoenhals, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 9, 2021
Radiation Therapy Enhanced by NBTXR3 Nanoparticles Overcomes Anti-PD1 Resistance and Evokes Abscopal Effects
Yun Hu, Sébastien Paris, Hampartsoum Barsoumian, et al.
Cancer Immunology Research
|
September 5, 2014
Combining radiation and immunotherapy: a new systemic therapy for solid tumors?
Chad Tang, Xiaohong Wang, Hendrick Soh, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 1, 2024
Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy
Kewen He, Nahum Puebla-Osorio, Hampartsoum B Barsoumian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 6, 2014
Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer
Maria Angelica Cortez, David Valdecanas, Xiaochun Zhang, et al.
Page
of 7